APA (7th ed.) Citation

CM, L., X, C., S, K., M, O., M, G., C, D., . . . RB, W. (2026). Immunophenotypic abnormality quantification refines multiparameter flow cytometry-based measurable residual disease testing in adults allografted for acute myeloid leukemia in morphologic remission. HemaSphere, 10(2), e70310. https://doi.org/10.1002/hem3.70310

Chicago Style (17th ed.) Citation

CM, Le, Chen X, Kodaira S, Othus M, Gang M, Davis C, Basom RS, Cherian S, and Walter RB. "Immunophenotypic Abnormality Quantification Refines Multiparameter Flow Cytometry-based Measurable Residual Disease Testing in Adults Allografted for Acute Myeloid Leukemia in Morphologic Remission." HemaSphere 10, no. 2 (2026): e70310. https://doi.org/10.1002/hem3.70310.

MLA (9th ed.) Citation

CM, Le, et al. "Immunophenotypic Abnormality Quantification Refines Multiparameter Flow Cytometry-based Measurable Residual Disease Testing in Adults Allografted for Acute Myeloid Leukemia in Morphologic Remission." HemaSphere, vol. 10, no. 2, 2026, p. e70310, https://doi.org/10.1002/hem3.70310.